Monthly shot tested to help hospital patients stay in opioid treatment
NCT ID NCT04345718
Summary
This study tested whether a single monthly injection of buprenorphine (XR-BUP) worked better than standard daily medications at helping hospitalized patients with opioid addiction stay in treatment after going home. About 344 adults with moderate to severe opioid addiction were randomly assigned to get either the monthly shot or one of the usual daily treatments right before hospital discharge. Researchers then checked if patients were still receiving legitimate addiction medication 34, 90, and 180 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston University
Boston, Massachusetts, 02118, United States
-
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, 55404, United States
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.